DIAGNOSTIC SIGNIFICANCE OF DETERMINING THE LEVEL OF EXTRACELLULAR FETAL DNA IN PREGNANT WOMEN WITH PREECLAMPSIA AND FETAL GROWTH RESTRICTION
- Авторлар: Sadekova A.A.1, Khachatryan Z.V.1, Krasnyi A.M.1,2, Kan N.E.1, Khachaturyan A.A.1, Tyutyunnik V.L.1
-
Мекемелер:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- N.K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences
- Шығарылым: № 8 (2019)
- Беттер: 144-149
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248702
- DOI: https://doi.org/10.18565/aig.2019.8.144-149
- ID: 248702
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
Alsu Sadekova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: a_sadekova@oparina4.ru
scientific researcher of the cytology laboratory
Zarine Khachatryan
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: z.v.khachatryan@gmail.com
postgraduate student
Aleksey Krasnyi
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; N.K. Koltsov Institute of Developmental Biology, Russian Academy of Sciences
Email: alexred@list.ru
PhD, the head of the cytology laboratory
Natalia Kan
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: kan-med@mail.ru
PhD, MD, the head of the obstetric department
Anuta Khachaturyan
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: x.anyt37@mail.ru
postgraduate student
Victor Tyutyunnik
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: tioutiounnik@mail.ru
PhD, MD, the head of the obstetric physiological department
Әдебиет тізімі
- Макаров И.О., Юдина Е.В., Боровкова Е.И. Задержка роста плода. Врачебная тактика: Учебн. пособие / 3-е изд. М.: МЕДпресс-информ, 2016; 56 с.
- Gardosi J., Madurasinghe V., Williams M., Malik A., Francis A. Maternal and fetal risk factors for stillbirth: population based study 2013; BMJ 346 (7893): 15.
- Alberry M., Maddocks D., Jones M., Abdel Hadi M., Abdel-Faiiah S., Avent N., Soothill P.W. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007; 27: 415-418.
- Burton G.J., Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. Am J Obstet Gynecol 2018 Feb; 218(2S): S745-S761.
- Kwiatkowski S., Dolegowska B., Kwiatkowska E., Rzepka R., Marczuk N., Loj B., Torbe A. Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction. J Perinat Med. 2017 Oct 26; 45 (7): 793-802.
- Colin P. Sibley. Treating the dysfunctional placenta, J Endocrinol. 2017 Aug; 234 (2): R81-R97.
- Dugoff L., Lynch A.M., Cioffi-Ragan D., Bobbins J.C., SchultzL.K., Malone F.D., D’Alton M.E.; FASTER Trial Research Consortium. First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction. Am J Obstet Gynecol. 2005 Sep; 193 (3 Pt 2): 1208-12.
- Albaiges G., Missfelder-Lobos H., Lees C., Parra M., Nicolaides K.H. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’ gestation. Obstet Gynecol 2000 Oct; 96 (4): 559-64.
- Yamamoto R., Ishii K., Nakajima E., Sasahara J., Mitsuda. Ultrasonographic prediction of antepartum deterioration of growth-restricted fetuses after late preterm. J Obstet Gynaecol Res. 2018 Jun; 44 (6): 1057-62.
- Berkley E., Chauhan S.P., Abu ham ad A. Doppler assessment of the fetus with intrauterine growth restriction. Society for Maternal-Fetal Medicine Publications Committee. Am J Obstet Gynecol. 2012 Apr; 206 (4): 300-8.
- Figueras F., Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol 2011 Apr; 204 (4): 288-300.
- Resnik R. Fetal growth restriction: evaluation and management. www.uptodate. com 2012.
- Figueras F., Gratacos E. Update on the Diagnosis and Classification of Fetal Growth Restriction and Proposal of a Stage-Based Management Protocol. Fetal Diagn Ther 2014; 36: 86-98
- Imdad A., Bautista R.M., Senen K.A., Uy M.E., Mantaring J.B. 3rd, Bhutta Z.A. Umbilical cord antiseptics for preventing sepsis and death among newborns. Cochrane Database Syst Rev. 2013 May 31; (5): CD008635
- Cruz-Martinez R., Figueras F., Hernandez-Andrade E., Puerto B., Gratacos E. Longitudinal brain perfusion changes in near term small for gestational age fetuses as measured by spectra Doppler-indices or by fractional moving blood volume. Am J Obstet Gynecol 2010; 203: 42.el-6.
- Unterscheider J., Daly S., Geary M.P., Kennedy M.M., McAuliffe F.M., O’Donoghue K., Hunter A., Morrison J.J., Burke G., Dicker P., Tully E.C., Malone F.D. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol. 2013 Apr; 208 (4): 290.e1-6.
- Salvianti F., Inversetti A., Smid M., Valsecchi L., Candiani M., Pazzagli M., Cremonesi L., Ferrari M., Pinzani P., Galbiati S. Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia. Placenta 2015; Sep; 36 (9): 996-1001.
- Papantoniou N., Bagiokos V., Agiannitopoulos K., Kolialexi A., Destouni A., Tounta G., Kanavakis E., Antsaklis A., Mavrou A. RASSF1A in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn. 2013 Jul; 33 (7): 682-7.
- Красный А.М., Грачева М.И., Садекова А.А., Вторушина В.В., Балашов И.С., Кан Н.Е., Боровиков П.И., Кречетова Л.В., Тютюнник В.Л. Комбинированное исследование общей, фетальной ДНК, цитокинов в плазме крови матери при преэклампсии. Бюллетень экспериментальной биологии и медицины 2018; 12: 686-91
- Jorgez C.J., Bischoff F.Z. Improving Enrichment of Circulating Fetal DNA for Genetic Testing: Size Fractionation Followed by Whole Gene Amplification. Fetal Diagn Ther. 2009 Sep; 25 (3): 31-319
- White H.E., Dent C.L., Hall V.J., Crolla J.A., Chitty L.S. Evaluation of a Novel Assay for Detection of the Fetal Marker RASSF1A: Facilitating Improved Diagnostic Reliability of Noninvasive Prenatal Diagnosis. PLoS One 2012; 7 (9): e45073.
- Fenton T.R, Kim J.H. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatrics 2013; 13 (1): 59.
- КарапетянА.О., Красный А.М., Садекова А.А., ХлестоваГ.В., Балашов И.С., Баев О.Р. Изменение концентрации внеклеточной ДНК во время беременности. Акушерство и гинекология 2018; 3: 44-50.
- Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, Abdel-Fattah SA, Avent ND, Soothill PW. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol. 2009 Jan;200(1):98.e1-6.
- Litwinska E, Litwinska M, Oszukowski P, Szaflik K, Kaczmarek P. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers. Adv Clin Exp Med. 2017 May-Jun; 26 (3): 439-448.
- Munoz-Hernandez R, Medrano-Campillo P, Miranda ML, Macher HC, Praena-FernandezJM, Vallejo-VazAJ, Dominguez-SimeonMJ, Moreno-LunaR, Stiefel P Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome. Am J Hypertens. 2017 Jul 1;30(7):673-682.
- Smid M, Galbiati S, Lojacono A, Valsecchi L, Platto C, Cavoretto P, Calza S, Ferrari A, Ferrari M, Cremonesi L. Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies. Prenat Diagn 2006; 26: 785-790.
- Al Nakib M, Desbriere R, Bonello N, Bretelle F, Boubli L, Gabert J, Levy-Mozziconacci A. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther. 2009; 26 (1): 24-8.
- Stein W Muller S, Gutensohn K, Emons G, Legler T. Cell-free fetal DNA and adverse outcome in low risk pregnancies. Eur J Obstet Gynecol Reprod Biol. 2013 Jan; 166 (1): 10-3.
- Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH. Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks’ gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther. 2013; 33 (4): 215-23.
- Koide K, Sekizawa A, Iwasaki M, Matsuoka R, Honma S, Farina A, Saito H, Okai T. Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. Prenat Diagn. 2005 Jul; 25 (7): 604-7.
Қосымша файлдар
![](/img/style/loading.gif)